作者:Fumio Tsuji、Yurika Miyake、Masato Horiuchi、Shiro Mita
DOI:10.1016/s0006-2952(97)00464-4
日期:1998.2
Leukotriene B-4 (LTB4) is a product of the 5-lipoxygenase pathway of arachidonic acid (AA) metabolism. LTB4 is a potent chemotactic factor for neutrophils and has been postulated to play an important role in a variety of pathological conditions including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. To investigate the role of LTB4 in dermatitis, we used S-(4-dimethylaminobenzyl)-N-[(2S) -mercapto-2-methylpropionyl]-L-cysteine (SA6541), a potent leukotriene A(4) (LTA(4)) hydrolase inhibitor. SA6541 inhibited LTB4 production with an IC50 value of 270 nM in vitro. 5-Hydroperoxyeicosatetraenoic acid (5-HPETE) or AA injection induced LTB4 production and neutrophil influx in mouse ear. SA6541 inhibited 5-HPETE- and AA-induced LTB4 production and neutrophil influx in mouse ear when administered orally at a dose of 50 mg/kg. SA6541 also inhibited 5-HPETE induced prostaglandin E-2 (PGE(2)) production, probably by an indirect effect through the inhibition of LTB4 production. These results suggest that LTB4 map be important in the pathogenesis of dermatitides such as psoriasis. (C) 1998 Elsevier Science Inc.